Refine Search
(4)
(5)
(6)
(6)

Dermatology

Currently, skin conditions are ranked as the 18th leading cause of global disability-adjusted life years (DALYs), which refer to the years lived with disability. Approximately one-fourth of the US population i.e. 84.5 million was affected by skin disease in 2013 (Source: American Academy of Dermatology). Across the 7MM, the population suffering from acne vulgaris and atopic dermatitis stood at 128.9 million and 34.5 million, respectively, in 2017.

Pruritus - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pruritus - Pipeline Review, H2 2018’, provides an overview of the Pruritus pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pruritus, complete with anal...

Burns - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Burns - Pipeline Review, H2 2018’, provides an overview of the Burns pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Burns, complete with analysis by s...

Scar - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Scar - Pipeline Review, H2 2018’, provides an overview of the Scar pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Scar, complete with analysis by stag...

Alopecia - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Alopecia - Pipeline Review, H2 2018’, provides an overview of the Alopecia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Alopecia, complete with anal...

Bullous Pemphigoid - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bullous Pemphigoid - Pipeline Review, H1 2018’, provides an overview of the Bullous Pemphigoid pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bullous ...

Wounds - Pipeline Review, H2 2017

  • $2,000
  • December 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Wounds - Pipeline Review, H2 2017’, provides an overview of the Wounds pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Wounds, complete with analysis b...